- Home
- COGT vs VRNT Comparison
COGT vs VRNT Comparison
Compare COGT & VRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- VRNT
- Stock Information
- Founded
- COGT 2014
- VRNT 1994
- Country
- COGT United States
- VRNT United States
- Employees
- COGT N/A
- VRNT N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- VRNT EDP Services
- Sector
- COGT Health Care
- VRNT Technology
- Exchange
- COGT Nasdaq
- VRNT Nasdaq
- Market Cap
- COGT 1.1B
- VRNT 1.2B
- IPO Year
- COGT 2018
- VRNT N/A
- Fundamental
- Price
- COGT $12.36
- VRNT $20.31
- Analyst Decision
- COGT Strong Buy
- VRNT Hold
- Analyst Count
- COGT 11
- VRNT 6
- Target Price
- COGT $21.20
- VRNT $25.60
- AVG Volume (30 Days)
- COGT 1.5M
- VRNT 3.2M
- Earning Date
- COGT 11-11-2025
- VRNT 09-02-2025
- Dividend Yield
- COGT N/A
- VRNT N/A
- EPS Growth
- COGT N/A
- VRNT 10.62
- EPS
- COGT N/A
- VRNT 0.74
- Revenue
- COGT N/A
- VRNT $893,843,000.00
- Revenue This Year
- COGT N/A
- VRNT $7.73
- Revenue Next Year
- COGT N/A
- VRNT $5.67
- P/E Ratio
- COGT N/A
- VRNT $27.57
- Revenue Growth
- COGT N/A
- VRNT N/A
- 52 Week Low
- COGT $3.72
- VRNT $14.15
- 52 Week High
- COGT $13.50
- VRNT $34.80
- Technical
- Relative Strength Index (RSI)
- COGT 52.66
- VRNT 50.26
- Support Level
- COGT $12.28
- VRNT $20.29
- Resistance Level
- COGT $13.13
- VRNT $20.37
- Average True Range (ATR)
- COGT 0.52
- VRNT 0.06
- MACD
- COGT -0.08
- VRNT 0.02
- Stochastic Oscillator
- COGT 30.06
- VRNT 15.38
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About VRNT Verint Systems Inc.
Verint Systems Inc with its subsidiaries, helps brands provide Boundless customer experience (CX) automation. AI offers a solution, and that's where Verint comes in. It empowers brands with groundbreaking AI via a next-gen open platform. Its Verint Open Platform helps organizations increase CX automation to achieve their strategic objectives and realize ROI. Geographically, it derives a majority of its revenue from the United States.